194 related articles for article (PubMed ID: 3552044)
1. Subunit interface of triosephosphate isomerase: site-directed mutagenesis and characterization of the altered enzyme.
Casal JI; Ahern TJ; Davenport RC; Petsko GA; Klibanov AM
Biochemistry; 1987 Mar; 26(5):1258-64. PubMed ID: 3552044
[TBL] [Abstract][Full Text] [Related]
2. Control of oligomeric enzyme thermostability by protein engineering.
Ahern TJ; Casal JI; Petsko GA; Klibanov AM
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):675-9. PubMed ID: 3543933
[TBL] [Abstract][Full Text] [Related]
3. Triosephosphate isomerase: removal of a putatively electrophilic histidine residue results in a subtle change in catalytic mechanism.
Nickbarg EB; Davenport RC; Petsko GA; Knowles JR
Biochemistry; 1988 Aug; 27(16):5948-60. PubMed ID: 2847777
[TBL] [Abstract][Full Text] [Related]
4. Crystallography and site-directed mutagenesis of yeast triosephosphate isomerase: what can we learn about catalysis from a "simple" enzyme?
Alber TC; Davenport RC; Giammona DA; Lolis E; Petsko GA; Ringe D
Cold Spring Harb Symp Quant Biol; 1987; 52():603-13. PubMed ID: 3331346
[No Abstract] [Full Text] [Related]
5. Probing the catalytic mechanism of yeast triose phosphate isomerase by site-specific mutagenesis.
Petsko GA; Davenport RC; Frankel D; RaiBhandary UL
Biochem Soc Trans; 1984 Apr; 12(2):229-32. PubMed ID: 6373437
[No Abstract] [Full Text] [Related]
6. Triose-phosphate isomerase of Leishmania mexicana mexicana. Cloning and characterization of the gene, overexpression in Escherichia coli and analysis of the protein.
Kohl L; Callens M; Wierenga RK; Opperdoes FR; Michels PA
Eur J Biochem; 1994 Mar; 220(2):331-8. PubMed ID: 8125090
[TBL] [Abstract][Full Text] [Related]
7. Active site of triosephosphate isomerase: in vitro mutagenesis and characterization of an altered enzyme.
Straus D; Raines R; Kawashima E; Knowles JR; Gilbert W
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2272-6. PubMed ID: 3887397
[TBL] [Abstract][Full Text] [Related]
8. Searching sequence space by definably random mutagenesis: improving the catalytic potency of an enzyme.
Hermes JD; Blacklow SC; Knowles JR
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):696-700. PubMed ID: 1967829
[TBL] [Abstract][Full Text] [Related]
9. Reaction energetics of a mutant triosephosphate isomerase in which the active-site glutamate has been changed to aspartate.
Raines RT; Sutton EL; Straus DR; Gilbert W; Knowles JR
Biochemistry; 1986 Nov; 25(22):7142-54. PubMed ID: 2879556
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of trypanosomal triosephosphate isomerase in Escherichia coli and characterisation of a dimer-interface mutant.
Borchert TV; Pratt K; Zeelen JP; Callens M; Noble ME; Opperdoes FR; Michels PA; Wierenga RK
Eur J Biochem; 1993 Feb; 211(3):703-10. PubMed ID: 8436128
[TBL] [Abstract][Full Text] [Related]
11. Triosephosphate isomerase: energetics of the reaction catalyzed by the yeast enzyme expressed in Escherichia coli.
Nickbarg EB; Knowles JR
Biochemistry; 1988 Aug; 27(16):5939-47. PubMed ID: 3056516
[TBL] [Abstract][Full Text] [Related]
12. Active site properties of monomeric triosephosphate isomerase (monoTIM) as deduced from mutational and structural studies.
Schliebs W; Thanki N; Eritja R; Wierenga R
Protein Sci; 1996 Feb; 5(2):229-39. PubMed ID: 8745400
[TBL] [Abstract][Full Text] [Related]
13. In vitro deamidation of human triosephosphate isomerase.
Yüksel KU; Gracy RW
Arch Biochem Biophys; 1986 Aug; 248(2):452-9. PubMed ID: 3740839
[TBL] [Abstract][Full Text] [Related]
14. Segmental movement: definition of the structural requirements for loop closure in catalysis by triosephosphate isomerase.
Sampson NS; Knowles JR
Biochemistry; 1992 Sep; 31(36):8482-7. PubMed ID: 1390632
[TBL] [Abstract][Full Text] [Related]
15. Affinity labeling and characterization of the active site histidine of glucosephosphate isomerase. Sequence homology with triosephosphate isomerase.
Gibson DR; Gracy RW; Hartman FC
J Biol Chem; 1980 Oct; 255(19):9369-74. PubMed ID: 7410429
[TBL] [Abstract][Full Text] [Related]
16. Three hTIM mutants that provide new insights on why TIM is a dimer.
Mainfroid V; Terpstra P; Beauregard M; Frère JM; Mande SC; Hol WG; Martial JA; Goraj K
J Mol Biol; 1996 Mar; 257(2):441-56. PubMed ID: 8609635
[TBL] [Abstract][Full Text] [Related]
17. Design, creation, and characterization of a stable, monomeric triosephosphate isomerase.
Borchert TV; Abagyan R; Jaenicke R; Wierenga RK
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1515-8. PubMed ID: 8108439
[TBL] [Abstract][Full Text] [Related]
18. Structural effects of a dimer interface mutation on catalytic activity of triosephosphate isomerase. The role of conserved residues and complementary mutations.
Banerjee M; Balaram H; Balaram P
FEBS J; 2009 Aug; 276(15):4169-83. PubMed ID: 19583769
[TBL] [Abstract][Full Text] [Related]
19. Differential effects on enzyme stability and kinetic parameters of mutants related to human triosephosphate isomerase deficiency.
Cabrera N; Torres-Larios A; García-Torres I; Enríquez-Flores S; Perez-Montfort R
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1401-1409. PubMed ID: 29571745
[TBL] [Abstract][Full Text] [Related]
20. Dissection of the gene of the bifunctional PGK-TIM fusion protein from the hyperthermophilic bacterium Thermotoga maritima: design and characterization of the separate triosephosphate isomerase.
Beaucamp N; Hofmann A; Kellerer B; Jaenicke R
Protein Sci; 1997 Oct; 6(10):2159-65. PubMed ID: 9336838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
